Cargando…
Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States
Increasing use of immunosuppressive biologic therapies poses a challenge for infectious diseases. Immunosuppressed patients have a high risk for influenza complications and an impaired immune response to vaccines. The total burden of immunosuppressive conditions in the United States, including those...
Autores principales: | Patel, Manish, Chen, Jufu, Kim, Sara, Garg, Shikha, Flannery, Brendan, Haddadin, Zaid, Rankin, Danielle, Halasa, Natasha, Talbot, H. Keipp, Reed, Carrie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392442/ https://www.ncbi.nlm.nih.gov/pubmed/32348234 http://dx.doi.org/10.3201/eid2608.191493 |
Ejemplares similares
-
Comparison of Osteoporosis Pharmacotherapy Fracture Rates: Analysis of a MarketScan(®) Claims Database Cohort
por: Reynolds, Alan W, et al.
Publicado: (2018) -
Rates of Vascular Events in Patients With Migraine: A MarketScan(®) Database Retrospective Cohort Study
por: Gill, Karminder, et al.
Publicado: (2020) -
Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis
por: Adrianzen-Herrera, Diego, et al.
Publicado: (2022) -
The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases
por: Curtis, Jeffrey R., et al.
Publicado: (2021) -
RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databases
por: Tran, Phuong T., et al.
Publicado: (2022)